Summary of Purpose
To collect the background characteristics of juvenile cerebral palsy patients aged 2-year or older prescribed BOTOX for the treatment of equines foot due to lower limb spasticity, compare them with those of patients whose deaths or adverse drug reactions (ADRs) related to the possible spread of toxin are reported through the spontaneous ADR reporting system, and discuss potential risk factors for such ADRs.Read More →
The following dates are available for this trial. Trial information last updated on 6 June 2017.
|1 May 2010||7 Apr 2011||1 Aug 2010||1 Aug 2010||1 Jun 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Perspective: Retrospective
- Sampling: Probability Sample